Search Results

August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi "San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics Inc (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed In addition, Structure Therapeutics has completed dosing in a single ascending dose (SAD) Phase 1 study

Strong GPCR drug discovery decisions are built on structure, early risk awareness, and focused signal This week’s issue focuses on structure, early safety strategy, and the next wave of signal transduction GPCR University has undergone a structural redesign. Align your team around structured learning outcomes, not scattered slide decks. It is structured access and structured education.

Structured continuity.   explores the open-access 7TMR-Raft database cataloguing GPCR–lipid raft associations and the expanding therapeutic It is structured access to a field. It supports scientists refining expertise. Structured access creates momentum. Premium delivers that — consistently. Join Dr. GPCR Premium — Build Your Structured Advantage ➤

Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Atypical Structure

Explore structure-based design of purinergic GPCR modulators with NIH scientist Kenneth A. . < Back Structure-Based Design of Modulators of Purinergic GPCRs March 12, 2026 at 2:00:00 PM 🔒 Watch This session examines how structure-based approaches have guided the discovery of selective ligands targeting A medicinal chemist specializing in the structure and pharmacology of G protein-coupled receptors and His research focuses on developing computational pipelines for rational ligand design targeting therapeutically

About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Structure-based